English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18076/20274 (89%)
造訪人次 : 5250180      線上人數 : 1192
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34403


    標題: The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment
    作者: Fang, Jing-Hung
    Chen, Yi-Chen
    Ho, Chung-Han
    Chen, Jui-Yi
    Hsing, Chung-Hsi
    Liang, Fu-Wen
    Wu, Chia-Chun
    貢獻者: Chi Mei Med Ctr, Dept Nephrol
    Chi Mei Med Ctr, Dept Med Res
    Chi Mei Med Ctr, Dept Anaesthesiol
    Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth
    Kaohsiung Med Univ Hosp, Dept Med Res
    Chia Nan Univ Pharm & Sci, Dept Pharm
    關鍵字: RETROSPECTIVE-COHORT
    ASPIRIN
    HEMORRHAGE
    WOMEN
    SCORE
    MEN
    日期: 2021
    上傳時間: 2023-11-11 11:49:58 (UTC+8)
    出版者: NATURE RESEARCH
    摘要: Patients with chronic kidney diseases (CKD) are often treated with antiplatelets due to aberrant haemostasis. This study aimed to evaluate the bleeding risk with CKD patients undergoing pentoxifylline (PTX) treatment with/without aspirin. In this retrospective study, we used Taiwan's National Health Insurance Research Database to identify PTX treated CKD patients. Patients undergoing PTX treatment after CKD diagnosis were PTX group. A 1:4 age, sex and aspirin used condition matched CKD patients non-using PTX were identified as controls. The outcome was major bleeding event (MBE: intracranial haemorrhage (ICH) and gastrointestinal tract bleeding) during 2-year follow-up period. Risk factors were estimated using Cox regression for overall and stratified analysis. The PTX group had higher MBE risk than controls (hazard ratio (HR) 1.19; 95% confidence interval (CI) 0.94-1.50). In stratified analysis, hyperlipidaemia was a significant risk factor (HR: 1.42; 95% CI 1.01-2.01) of MBE. A daily PTX dose larger than 800 mg, females, non-regular aspirin usage, and ischaemic stroke were risk factors for MBE in PTX group. When prescribing PTX in CKD patients, bleeding should be closely monitored, especially in those with daily dose more than 800 mg, aspirin users, and with a history of ischaemic stroke.
    關聯: SCI REP-UK, v.11, n.1
    顯示於類別:[藥學系(所)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML278檢視/開啟
    s41598-021-92753-4.pdf1073KbAdobe PDF115檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋